Celularity Inc. Payments to Acquire Investments to be Held in Decommissioning Trust Fund
Celularity Inc. (CELU) reported Payments to Acquire Investments to be Held in Decommissioning Trust Fund of $137.50 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-24.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToInvestInDecommissioningFund · last filed 2021-05-24
- Celularity Inc. payments to acquire investments to be held in decommissioning trust fund for the quarter ending 2020-12-31 was $0.00.
- Celularity Inc. payments to acquire investments to be held in decommissioning trust fund for the quarter ending 2019-12-31 was $0.00.
- Celularity Inc. payments to acquire investments to be held in decommissioning trust fund for the quarter ending 2019-09-30 was $0.00.
- Celularity Inc. payments to acquire investments to be held in decommissioning trust fund for fiscal 2020 was $137.50K, a 99.95% decline from fiscal 2019.
- Celularity Inc. payments to acquire investments to be held in decommissioning trust fund for fiscal 2019 was $287.50M.
| Period end | Payments to Acquire Investments to be Held in Decommissioning Trust Fund 3 month | Payments to Acquire Investments to be Held in Decommissioning Trust Fund 6 month | Payments to Acquire Investments to be Held in Decommissioning Trust Fund 9 month | Payments to Acquire Investments to be Held in Decommissioning Trust Fund 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $137.50K 10-K/A · filed 2021-05-24 | ||
| 2020-09-30 | $137.50K 10-Q · filed 2020-11-16 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $0.00 derived: sum of 2 quarters · filed 2021-05-24 | $287.50M 10-K/A · filed 2021-05-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $287.50M 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $287.50M 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |